Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SMARCA5 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SMARCA5 mRNA | CTD | PMID:22206623 | SMARCA5 | Human | 1,2-dimethylhydrazine | affects expression | ISO | Smarca5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of SMARCA5 mRNA | CTD | PMID:22206623 | SMARCA5 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SMARCA5 mRNA | CTD | PMID:17942748 | SMARCA5 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA5 mRNA | CTD | PMID:17942748 | SMARCA5 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:32352317 | SMARCA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of SMARCA5 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA5 mRNA | CTD | PMID:15251184 and PMID:17942748 | SMARCA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SMARCA5 mRNA | CTD | PMID:33387578 | SMARCA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SMARCA5 mRNA | CTD | PMID:34747641 | SMARCA5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Smarca5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SMARCA5 mRNA | CTD | PMID:24680724 | SMARCA5 | Human | 2,4,6-tribromophenol | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | SMARCA5 | Human | 2,6-dinitrotoluene | affects expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of SMARCA5 mRNA | CTD | PMID:21346803 | SMARCA5 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of SMARCA5 mRNA | CTD | PMID:21179406 | SMARCA5 | Human | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of SMARCA5 protein | CTD | PMID:31675489 | SMARCA5 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of SMARCA5 gene | CTD | PMID:31601247 | SMARCA5 | Human | 5-aza-2'-deoxycytidine | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of SMARCA5 mRNA | CTD | PMID:15251184 | SMARCA5 | Human | 5-aza-2'-deoxycytidine | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Decitabine results in increased expression of SMARCA5 mRNA | CTD | PMID:15251184 | SMARCA5 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SMARCA5 mRNA | CTD | PMID:17045167 | SMARCA5 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SMARCA5 mRNA | CTD | PMID:33212167 | SMARCA5 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SMARCA5 mRNA] | CTD | PMID:32406909 | SMARCA5 | Human | bisphenol A | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SMARCA5 mRNA | CTD | PMID:26063408 | SMARCA5 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SMARCA5 protein | CTD | PMID:37567409 | SMARCA5 | Human | bisphenol A | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SMARCA5 mRNA | CTD | PMID:25181051 | SMARCA5 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of SMARCA5 protein | CTD | PMID:35688186 | SMARCA5 | Human | chlorpyrifos | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SMARCA5 mRNA | CTD | PMID:37019170 | SMARCA5 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SMARCA5 mRNA | CTD | PMID:27392435 | SMARCA5 | Human | cocaine | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Cocaine results in increased expression of SMARCA5 mRNA | CTD | PMID:27053203 | SMARCA5 | Human | cocaine | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [SMARCA5 protein co-treated with BAZ1B protein] results in increased susceptibility to Cocaine | CTD | PMID:27053203 | SMARCA5 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SMARCA5 mRNA | CTD | PMID:20106945 | SMARCA5 | Human | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of SMARCA5 protein | CTD | PMID:31675489 | SMARCA5 | Human | dibutyl phthalate | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SMARCA5 mRNA | CTD | PMID:21266533 | SMARCA5 | Human | dibutyl phthalate | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of SMARCA5 mRNA | CTD | PMID:21266533 | SMARCA5 | Human | diclofenac | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Diclofenac results in increased expression of SMARCA5 mRNA | CTD | PMID:26934552 | SMARCA5 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SMARCA5 mRNA | CTD | PMID:29803840 | SMARCA5 | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of SMARCA5 mRNA | CTD | PMID:19244175 | SMARCA5 | Human | epoxiconazole | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SMARCA5 mRNA | CTD | PMID:35436446 | SMARCA5 | Human | folic acid | multiple interactions | ISO | Smarca5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SMARCA5 mRNA | CTD | PMID:22206623 | SMARCA5 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SMARCA5 mRNA | CTD | PMID:23649840 | SMARCA5 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of SMARCA5 protein | CTD | PMID:37730182 | SMARCA5 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of SMARCA5 gene | CTD | PMID:31601247 | SMARCA5 | Human | genistein | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Genistein results in increased expression of SMARCA5 mRNA | CTD | PMID:16169203 | SMARCA5 | Human | gentamycin | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of SMARCA5 mRNA | CTD | PMID:22061828 | SMARCA5 | Human | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of SMARCA5 mRNA | CTD | PMID:18951874 | SMARCA5 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of SMARCA5 mRNA | CTD | PMID:21179406 | SMARCA5 | Human | hypochlorous acid | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of SMARCA5 mRNA | CTD | PMID:19376150 | SMARCA5 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SMARCA5 protein | CTD | PMID:32959892 | SMARCA5 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of SMARCA5 mRNA | CTD | PMID:28903495 | SMARCA5 | Human | miconazole | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Miconazole results in decreased expression of SMARCA5 mRNA | CTD | PMID:27462272 | SMARCA5 | Human | motexafin gadolinium | decreases expression | EXP | | 6480464 | motexafin gadolinium results in decreased expression of SMARCA5 mRNA | CTD | PMID:16357179 | SMARCA5 | Human | motexafin gadolinium | multiple interactions | EXP | | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA5 mRNA | CTD | PMID:16357179 | SMARCA5 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SMARCA5 protein | CTD | PMID:26558463 | SMARCA5 | Human | N-nitrosodiethylamine | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of SMARCA5 mRNA | CTD | PMID:19041683 | SMARCA5 | Human | N-nitrosomorpholine | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | N-nitrosomorpholine results in increased expression of SMARCA5 protein | CTD | PMID:19716841 | SMARCA5 | Human | oxaliplatin | decreases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of SMARCA5 mRNA | CTD | PMID:25729387 | SMARCA5 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SMARCA5 mRNA | CTD | PMID:21420995 | SMARCA5 | Human | phenobarbital | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of SMARCA5 mRNA | CTD | PMID:23091169 | SMARCA5 | Human | phenytoin | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Phenytoin results in increased expression of SMARCA5 mRNA | CTD | PMID:20345932 | SMARCA5 | Human | piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of SMARCA5 mRNA | CTD | PMID:21858171 | SMARCA5 | Human | resveratrol | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | resveratrol results in decreased expression of SMARCA5 protein | CTD | PMID:25505154 | SMARCA5 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SMARCA5 mRNA | CTD | PMID:23557933 | SMARCA5 | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of SMARCA5 mRNA | CTD | PMID:19244175 | SMARCA5 | Human | silicon dioxide | increases methylation | EXP | | 6480464 | Silicon Dioxide results in increased methylation of SMARCA5 gene | CTD | PMID:34973136 | SMARCA5 | Human | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of SMARCA5 gene | CTD | PMID:28589171 | SMARCA5 | Human | Soman | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Soman results in increased expression of SMARCA5 mRNA | CTD | PMID:19281266 | SMARCA5 | Human | tetrachloromethane | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SMARCA5 mRNA | CTD | PMID:27339419 and PMID:31919559 | SMARCA5 | Human | tetrahydropalmatine | decreases expression | EXP | | 6480464 | tetrahydropalmatine results in decreased expression of SMARCA5 protein | CTD | PMID:20109541 | SMARCA5 | Human | thioacetamide | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SMARCA5 mRNA | CTD | PMID:34492290 | SMARCA5 | Human | trichloroethene | decreases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of SMARCA5 mRNA | CTD | PMID:33387578 | SMARCA5 | Human | trimellitic anhydride | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SMARCA5 mRNA | CTD | PMID:19042947 | SMARCA5 | Human | triptonide | increases expression | ISO | Smarca5 (Mus musculus) | 6480464 | triptonide results in increased expression of SMARCA5 mRNA | CTD | PMID:33045310 | SMARCA5 | Human | tungsten | decreases expression | ISO | Smarca5 (Mus musculus) | 6480464 | Tungsten results in decreased expression of SMARCA5 mRNA | CTD | PMID:30912803 | SMARCA5 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SMARCA5 mRNA | CTD | PMID:23179753 | SMARCA5 | Human | vinclozolin | decreases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of SMARCA5 mRNA | CTD | PMID:18042343 | SMARCA5 | Human | vinclozolin | increases expression | ISO | Smarca5 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SMARCA5 mRNA | CTD | PMID:23034163 | SMARCA5 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of SMARCA5 mRNA | CTD | PMID:19244175 | SMARCA5 | Human | zinc acetate | multiple interactions | EXP | | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA5 mRNA | CTD | PMID:16357179 | SMARCA5 | Human | zinc acetate | decreases expression | EXP | | 6480464 | Zinc Acetate results in decreased expression of SMARCA5 mRNA | CTD | PMID:16357179 | |